Two-pronged therapeutic technology for cancer wins Pfizer Prize for Biomedical Research 2026

Pfizer

Hôpitaux Universitaires de Genève Jan 29 2026 Whereas conventional treatments such as chemotherapy and radiotherapy show their limitations in battling certain advanced cancers, immunotherapy and therapeutic vaccines have opened up a new realm of hope for patients. The underlying principle is that they mobilize the body's natural defences to target tumor cells. Despite spectacular results in some cases, the complexity of tumors and the heterogeneity of immune profiles complicate the development

Tag-uri: Pfizer

din zilele anterioare